Loading
NASDAQHealthcareBiotechnology
Latest quote
$4.00
−$0.19 · -4.53%
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
Regular session
$4.00
−$0.19 · -4.53%
Regular session · ET · Market data may be delayed.
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
Day range
Current $4.00
52-week range
Current $4.00
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
24
Expensive
Sentiment
57
Mixed
Risk
55
Elevated Risk
Momentum
56
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
Day range
Current $4.00
52-week range
Current $4.00
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 7.15M USD | 25.98M USD | 24.35M USD | 15.22M USD | 1.12M USD |
| Cost of goods sold | 760K USD | 54.05M USD | 51.74M USD | 34M USD | 19.67M USD |
| Gross profit | 6.39M USD | −28.07M USD | −27.38M USD | −18.78M USD | −18.55M USD |
| Research and development | 90.96M USD | 51.03M USD | 48.93M USD | 32.66M USD | 19.67M USD |
| Selling, general, and administrative | 29.82M USD | 36.75M USD | 44.55M USD | 40.18M USD | 18.51M USD |
| Operating expenses | 120.79M USD | 39.39M USD | 44.55M USD | 43.9M USD | 92.67M USD |
| Interest income | 6.23M USD | 3.93M USD | 6.4M USD | 2.4M USD | 13K USD |
| Interest expense | — | 154K USD | 231K USD | 230K USD | 665K USD |
| Depreciation and amortization | 79K USD | 193K USD | 169K USD | 159K USD | 105K USD |
| Operating income | −114.4M USD | −67.46M USD | −71.93M USD | −62.68M USD | −111.22M USD |
| Net income | −20.6M USD | −63.69M USD | −65.77M USD | −60.51M USD | −110.09M USD |
Company facts updated Sep 10, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$8.00
100.00% upside| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Aug 27, 2021 | 15:1 | — | — |
Effective Aug 27, 2021
15:1
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI3.42M0.00%2.3T USD0.03%$373.38-0.58%
iShares Russell 2000 ETFIWM3M0.00%80.51B USD0.19%$288.18-0.85%
Vanguard Extended Market ETFVXF1.81M0.00%93.7B USD0.05%$236.94-0.73%
iShares Russell 2000 Value ETFIWN1.3M0.01%14.61B USD0.24%$218.86-0.73%
Vanguard Russell 2000 ETFVTWO699.33K0.00%17.4B USD0.06%$116.52-0.84%
iShares Micro-Cap ETFIWC460.26K0.03%1.49B USD0.60%$190.45-1.03%
Avantis U.S. Small Cap Equity ETFAVSC275.34K0.01%3.1B USD0.25%$71.11-0.70%
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETFGSSC227.14K0.02%1.08B USD0.20%$88.02-0.70%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFiShares Russell 2000 Value ETFIWNVanguard Russell 2000 ETFVTWOiShares Micro-Cap ETFIWCAvantis U.S. Small Cap Equity ETFAVSCGoldman Sachs ActiveBeta U.S. Small Cap Equity ETFGSSCAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
